AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 119 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,352,000 | +20.8% | 994,916 | -1.7% | 0.00% | +33.3% |
| Q2 2020 | $7,739,000 | +28.3% | 1,011,673 | +3.7% | 0.00% | 0.0% |
| Q1 2020 | $6,031,000 | -45.9% | 975,857 | +6.5% | 0.00% | -25.0% |
| Q4 2019 | $11,151,000 | -11.8% | 916,283 | -16.3% | 0.00% | -20.0% |
| Q3 2019 | $12,645,000 | +15.4% | 1,094,692 | -0.2% | 0.01% | +25.0% |
| Q2 2019 | $10,960,000 | -22.5% | 1,097,195 | -0.1% | 0.00% | -33.3% |
| Q1 2019 | $14,141,000 | -15.2% | 1,097,961 | -0.0% | 0.01% | -25.0% |
| Q4 2018 | $16,679,000 | -24.1% | 1,097,994 | -0.1% | 0.01% | 0.0% |
| Q3 2018 | $21,972,000 | +1.0% | 1,098,585 | -1.5% | 0.01% | -11.1% |
| Q2 2018 | $21,757,000 | -5.5% | 1,115,731 | -2.3% | 0.01% | -10.0% |
| Q1 2018 | $23,017,000 | +50.9% | 1,142,295 | -0.8% | 0.01% | +66.7% |
| Q4 2017 | $15,252,000 | -28.2% | 1,151,082 | -0.0% | 0.01% | -33.3% |
| Q3 2017 | $21,240,000 | -5.0% | 1,151,226 | -5.3% | 0.01% | -10.0% |
| Q2 2017 | $22,361,000 | -3.3% | 1,215,249 | +18.5% | 0.01% | -9.1% |
| Q1 2017 | $23,129,000 | +63.6% | 1,025,673 | +152.4% | 0.01% | +57.1% |
| Q4 2016 | $14,140,000 | +44.3% | 406,303 | +1.6% | 0.01% | +40.0% |
| Q3 2016 | $9,799,000 | +3.1% | 399,796 | +0.6% | 0.01% | 0.0% |
| Q2 2016 | $9,503,000 | +2.2% | 397,296 | 0.0% | 0.01% | -16.7% |
| Q1 2016 | $9,296,000 | -22.6% | 397,296 | -0.1% | 0.01% | -14.3% |
| Q4 2015 | $12,010,000 | -22.4% | 397,816 | +2.2% | 0.01% | -30.0% |
| Q3 2015 | $15,470,000 | -42.7% | 389,381 | -0.5% | 0.01% | -41.2% |
| Q2 2015 | $27,017,000 | +25.2% | 391,223 | -0.9% | 0.02% | +21.4% |
| Q1 2015 | $21,576,000 | +28.0% | 394,713 | -0.2% | 0.01% | +27.3% |
| Q4 2014 | $16,857,000 | +33.6% | 395,511 | 0.0% | 0.01% | +22.2% |
| Q3 2014 | $12,619,000 | +56.2% | 395,511 | +1.4% | 0.01% | +50.0% |
| Q2 2014 | $8,080,000 | +17.7% | 389,980 | +9.9% | 0.01% | +20.0% |
| Q1 2014 | $6,866,000 | -20.3% | 354,869 | +0.0% | 0.01% | -28.6% |
| Q4 2013 | $8,610,000 | +8.9% | 354,777 | -3.6% | 0.01% | 0.0% |
| Q3 2013 | $7,903,000 | -1.0% | 367,902 | +2.6% | 0.01% | -12.5% |
| Q2 2013 | $7,983,000 | – | 358,753 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4,060,000 | $46,893,000 | 3.11% |
| Camber Capital Management LP | 4,390,000 | $50,705,000 | 2.67% |
| Palo Alto Investors LP | 3,078,874 | $35,561,000 | 2.37% |
| Permanens Capital L.P. | 407,811 | $4,710,000 | 1.32% |
| Fondren Management LP | 35,000 | $404,000 | 0.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 33,524 | $387,000 | 0.29% |
| BOOTHBAY FUND MANAGEMENT, LLC | 240,000 | $2,772,000 | 0.25% |
| Broadfin Capital, LLC | 100,000 | $1,155,000 | 0.21% |
| FOX RUN MANAGEMENT, L.L.C. | 13,687 | $158,000 | 0.14% |
| Spark Investment Management LLC | 92,200 | $1,064,000 | 0.14% |